Answers are grounded in this paper and cite their sources.
The development of BODIPY-based theranostic agents for photodynamic inactivation (PDI) of pathogens is one of the rapidly developing areas. In this work, we present the results of the synthesis of the diiodo-BODIPY with methanol, (+)-myrtenol and thiotherpenoid conjugates. We performed a comparative analysis of the influence of the ester residue nature, iodination, and solvent properties on the spectral, generation characteristics and photostability of the alkyl- and diiodo-BODIPY conjugates, and their efficiency to penetrate and inhibit Candida albicans cells under light. Non-halogenated conjugates of BODIPY with methanol, (+)-myrtenol and thiotherpenoid show potential for fluorescence diagnostics due to their high fluorescence, photostability, and membranotropicity. Diiodo-substituted terpene-BODIPY conjugates have higher singlet oxygen generation efficiency and greater affinity for lipid biostructures compared to non-halogenated analogues. Furthermore, halogenation and conjugation of BODIPY to a monoterpenoid modify the preferred biotarget and contribute to the effective inhibition of Candida albicans viability. These results suggest that diiodo-substituted terpene-BODIPY conjugates may be promising antifungal agents for blocking fungal virulence. • I 2 -BODIPY with (+)-myrtenol and thioterpenoid conjugates were synthesized. • A comparative analysis of the structure influence on the dyes properties has been carried out. • Conjugates of I 2 -BODIPY with terpenes efficiently generate 1 О 2 and block fungal virulence. • Halogenation and conjugation of BODIPY with terpene residue increases affinity to the biotarget. • Terpene-BODIPY conjugates are promising theranostics for bioapplications.
No takes yet. Share an insight, caveat, or question.
Гусева et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: